Cargando…
Prospectively Isolated Cancer-Associated CD10(+) Fibroblasts Have Stronger Interactions with CD133(+) Colon Cancer Cells than with CD133(−) Cancer Cells
Although CD133 has been reported to be a promising colon cancer stem cell marker, the biological functions of CD133(+) colon cancer cells remain controversial. In the present study, we investigated the biological differences between CD133(+) and CD133(−) colon cancer cells, with a particular focus o...
Autores principales: | Cui, Lin, Ohuchida, Kenoki, Mizumoto, Kazuhiro, Moriyama, Taiki, Onimaru, Manabu, Nakata, Kohei, Nabae, Toshinaga, Ueki, Takashi, Sato, Norihiro, Tominaga, Yohei, Tanaka, Masao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920818/ https://www.ncbi.nlm.nih.gov/pubmed/20711432 http://dx.doi.org/10.1371/journal.pone.0012121 |
Ejemplares similares
-
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010) -
CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009) -
CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016) -
Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018) -
CD166/ALCAM Expression Is Characteristic of Tumorigenicity and Invasive and Migratory Activities of Pancreatic Cancer Cells
por: Fujiwara, Kenji, et al.
Publicado: (2014)